Cargando…
Supplementation With Bifidobacterium and Symptomatic Control in Irritable Bowel Syndrome: An Evidence-Based Review
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder, with a global prevalence of around 11%. Family doctors should be aware of the diagnosis and treatment of this pathology. The benefit of using probiotics is questionable. The purpose of this review is to establish the evidence...
Autores principales: | Terra, Inês, Santeiro, Catarina, da Fonseca Rua, Jenifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544091/ https://www.ncbi.nlm.nih.gov/pubmed/37791169 http://dx.doi.org/10.7759/cureus.44447 |
Ejemplares similares
-
Irritable Bowel Syndrome and Depression: A Shared Pathogenesis
por: Mudyanadzo, Tatenda A, et al.
Publicado: (2018) -
The Role of Gut-Microbiota in the Pathophysiology and Therapy of Irritable Bowel Syndrome: A Systematic Review
por: Shrestha, Bijay, et al.
Publicado: (2022) -
The Effects of Serotonin Receptor Type 7 Modulation on Bowel Sensitivity and Smooth Muscle Tone in Patients With Irritable Bowel Syndrome
por: Osman, Usama, et al.
Publicado: (2023) -
Impact of Work Hours on the Quality of Life of Adult Employees With Irritable Bowel Syndrome in Saudi Arabia
por: Alhuzaim, Waleed M, et al.
Publicado: (2022) -
Prevalence, Risk Factors, and Management of Irritable Bowel Syndrome in Saudi Arabia: A Systematic Review
por: Makkawy, Eyad A, et al.
Publicado: (2023)